Fisher Wallace Laboratories, Inc.
Regulation Crowdfunding offering on Dealmaker
$50,015
of $4.4M goal
1.1% funded
About the offering
Fisher Wallace Labs is a neurotech medical device company that develops prescription wearable brain stimulation devices to treat anxiety, depression, and insomnia in Brooklyn, New York.
FAQ
How much has Fisher Wallace Laboratories, Inc. raised?
Fisher Wallace Laboratories, Inc. has raised $50,015 of a $4.4M goal.
Where is Fisher Wallace Laboratories, Inc.'s campaign listed?
The offering is listed on Dealmaker, an SEC-registered Reg CF intermediary.
What are the terms of Fisher Wallace Laboratories, Inc.'s raise?
Common Stock, $122.27M cap, $11.38/share.
When does Fisher Wallace Laboratories, Inc.'s offering close?
The stated close date is Jul 31, 2026.